Robin Carhart‐Harris

7.0k total citations · 4 hit papers
65 papers, 3.9k citations indexed

About

Robin Carhart‐Harris is a scholar working on Clinical Psychology, Cellular and Molecular Neuroscience and Organic Chemistry. According to data from OpenAlex, Robin Carhart‐Harris has authored 65 papers receiving a total of 3.9k indexed citations (citations by other indexed papers that have themselves been cited), including 61 papers in Clinical Psychology, 36 papers in Cellular and Molecular Neuroscience and 31 papers in Organic Chemistry. Recurrent topics in Robin Carhart‐Harris's work include Psychedelics and Drug Studies (61 papers), Neurotransmitter Receptor Influence on Behavior (34 papers) and Chemical synthesis and alkaloids (31 papers). Robin Carhart‐Harris is often cited by papers focused on Psychedelics and Drug Studies (61 papers), Neurotransmitter Receptor Influence on Behavior (34 papers) and Chemical synthesis and alkaloids (31 papers). Robin Carhart‐Harris collaborates with scholars based in United Kingdom, United States and Canada. Robin Carhart‐Harris's co-authors include David Nutt, David Erritzøe, Mendel Kaelen, Leor Roseman, Robert Leech, Enzo Tagliazucchi, Dante R. Chialvo, Amanda Feilding, Eline Haijen and Rosalind Watts and has published in prestigious journals such as New England Journal of Medicine, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Robin Carhart‐Harris

58 papers receiving 3.7k citations

Hit Papers

4 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The entropic brain: a theory of conscious states informed by neuroimaging research with psychedelic drugs

2014 694 citations Robin Carhart‐Harris, Robert Leech et al. Frontiers in Human Neuroscience profile →
Psychedelics and the essential importance of context

2018 428 citations Robin Carhart‐Harris, Leor Roseman et al. Journal of Psychopharmacology profile →
The entropic brain - revisited

2018 279 citations Robin Carhart‐Harris profile →
Emotional breakthrough and psychedelics: Validation of the Emotional Breakthrough Inventory

2019 238 citations Leor Roseman, Eline Haijen et al. Journal of Psychopharmacology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Robin Carhart‐Harris United Kingdom	25	3.2k	1.6k	1.5k	623	544	65	3.9k
Michael Kometer Switzerland	22	2.4k 0.7×	1.2k 0.7×	1.5k 1.0×	589 0.9×	491 0.9×	37	3.1k
Mark Bolstridge United Kingdom	14	3.2k 1.0×	1.8k 1.1×	1.8k 1.2×	309 0.5×	539 1.0×	17	3.5k
Leor Roseman United Kingdom	36	5.0k 1.5×	2.6k 1.6×	2.5k 1.6×	829 1.3×	865 1.6×	76	5.9k
Mendel Kaelen United Kingdom	26	4.8k 1.5×	2.7k 1.7×	2.4k 1.6×	404 0.6×	822 1.5×	37	5.3k
Kim P. C. Kuypers Netherlands	39	2.9k 0.9×	1.3k 0.8×	1.7k 1.1×	498 0.8×	439 0.8×	127	4.3k
Christopher Timmermann United Kingdom	24	2.1k 0.6×	1.1k 0.7×	943 0.6×	325 0.5×	357 0.7×	60	2.5k
Katrin H. Preller Switzerland	40	4.2k 1.3×	2.0k 1.2×	2.9k 1.9×	1.1k 1.8×	755 1.4×	114	5.8k
Frederick S. Barrett United States	39	4.7k 1.4×	2.7k 1.7×	2.1k 1.4×	718 1.2×	758 1.4×	80	6.1k
Adam L. Halberstadt United States	37	3.4k 1.1×	1.8k 1.1×	2.6k 1.7×	308 0.5×	595 1.1×	90	4.6k
James Rucker United Kingdom	26	2.8k 0.9×	1.7k 1.1×	1.3k 0.9×	186 0.3×	314 0.6×	115	3.9k

Countries citing papers authored by Robin Carhart‐Harris

Since Specialization

Citations

This map shows the geographic impact of Robin Carhart‐Harris's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robin Carhart‐Harris with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robin Carhart‐Harris more than expected).

Fields of papers citing papers by Robin Carhart‐Harris

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robin Carhart‐Harris. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robin Carhart‐Harris. The network helps show where Robin Carhart‐Harris may publish in the future.

Co-authorship network of co-authors of Robin Carhart‐Harris

This figure shows the co-authorship network connecting the top 25 collaborators of Robin Carhart‐Harris. A scholar is included among the top collaborators of Robin Carhart‐Harris based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robin Carhart‐Harris. Robin Carhart‐Harris is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Giribaldi, Bruna, et al.. (2025). The effects of psilocybin therapy versus escitalopram on cognitive bias: A secondary analysis of a randomized controlled trial. European Neuropsychopharmacology. 97. 51–60. 1 indexed citations

Cardone, Paolo, Charlotte Martial, Yonatan Sanz Perl, et al.. (2025). A Virtual Clinical Trial of Psychedelics to Treat Patients With Disorders of Consciousness. Advanced Science. 13(11). e11780–e11780.

Singleton, S. Parker, Christopher Timmermann, Andrea I. Luppi, et al.. (2025). Network control energy reductions under DMT relate to serotonin receptors, signal diversity, and subjective experience. Communications Biology. 8(1). 631–631.

Goldberg, Simon B., Jacob T.N. Young, John J. Curtin, et al.. (2025). Can psychedelic use benefit meditation practice? Examining individual, psychedelic, and meditation-related factors. PLoS ONE. 20(2). e0310160–e0310160. 1 indexed citations

Pasquini, Lorenzo, Courtney L. Gallen, Hannes Kettner, et al.. (2025). Dynamic medial parietal and hippocampal deactivations under DMT relate to sympathetic output and altered sense of time, space, and the self. Imaging Neuroscience. 3.

Haijen, Eline, et al.. (2024). Validation of the imperial psychedelic predictor scale. Psychological Medicine. 54(12). 3539–3547.

Erritzøe, David, et al.. (2024). Psychedelics and the ‘inner healer’: Myth or mechanism?. Journal of Psychopharmacology. 38(5). 417–424. 9 indexed citations

Kettner, Hannes, et al.. (2024). Interactions between classic psychedelics and serotonergic antidepressants: Effects on the acute psychedelic subjective experience, well-being and depressive symptoms from a prospective survey study. Journal of Psychopharmacology. 38(2). 145–155. 13 indexed citations

Martial, Charlotte, Robin Carhart‐Harris, & Christopher Timmermann. (2024). Within-subject comparison of near-death and psychedelic experiences: acute and enduring effects. Neuroscience of Consciousness. 2024(1). niae033–niae033. 1 indexed citations

10.

Bear, Adam, et al.. (2024). The Relationship Between Changes in Mindfulness and Subsequent Changes in Well-Being Following Psychedelic Use: Prospective Cohort Study. JMIR Formative Research. 8. e54632–e54632.

11.

Vohryzek, Jakub, Joana Cabral, Christopher Timmermann, et al.. (2024). The flattening of spacetime hierarchy of the N,N-dimethyltryptamine brain state is characterized by harmonic decomposition of spacetime (HADES) framework. National Science Review. 11(5). nwae124–nwae124. 6 indexed citations

12.

Erritzøe, David, et al.. (2024). Effects of discontinuation of serotonergic antidepressants prior to psilocybin therapy versus escitalopram for major depression. Journal of Psychopharmacology. 38(5). 458–470. 14 indexed citations

13.

Ashton, Michael C., Fernando E. Rosas, Malin V. Uthaug, et al.. (2023). Psychological and physiological effects of extended DMT. Journal of Psychopharmacology. 38(1). 56–67. 20 indexed citations

14.

Luppi, Andrea I., Pedro A. M. Mediano, Fernando E. Rosas, et al.. (2023). A synergistic workspace for human consciousness revealed by Integrated Information Decomposition. eLife. 12. 16 indexed citations

15.

Forstmann, Matthias, Hannes Kettner, Christina Sagioglou, et al.. (2023). Among psychedelic-experienced users, only past use of psilocybin reliably predicts nature relatedness. Journal of Psychopharmacology. 37(1). 93–106. 14 indexed citations

16.

Simonsson, Otto, Per Carlbring, Robin Carhart‐Harris, et al.. (2023). Assessing the risk of symptom worsening in psilocybin-assisted therapy for depression: A systematic review and individual participant data meta-analysis. Psychiatry Research. 327. 115349–115349. 14 indexed citations

17.

Roseman, Leor, et al.. (2022). Changes in music-evoked emotion and ventral striatal functional connectivity after psilocybin therapy for depression. Journal of Psychopharmacology. 37(1). 70–79. 19 indexed citations

18.

Spriggs, Meg J., Bruna Giribaldi, Taylor Lyons, et al.. (2022). Body mass index (BMI) does not predict responses to psilocybin. Journal of Psychopharmacology. 37(1). 107–116. 12 indexed citations

19.

Alamia, Andrea, Christopher Timmermann, David Nutt, Rufin VanRullen, & Robin Carhart‐Harris. (2020). DMT alters cortical travelling waves. eLife. 9. 50 indexed citations

20.

Carhart‐Harris, Robin, Robert Leech, Peter J. Hellyer, et al.. (2014). The entropic brain: a theory of conscious states informed by neuroimaging research with psychedelic drugs. Frontiers in Human Neuroscience. 8. 20–20. 694 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact